![Charles Joseph Magolske](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charles Joseph Magolske
Directeur Général chez Artin Bioscience, Inc.
Postes actifs de Charles Joseph Magolske
Sociétés | Poste | Début | Fin |
---|---|---|---|
Artin Bioscience, Inc.
![]() Artin Bioscience, Inc. BiotechnologyHealth Technology Artin Bioscience, Inc. is an American US-based company that is pioneering precision therapeutics to treat serious diseases triggered by intestinal inflammation. The company is creating a new class of transformative precision therapeutics that target and block the root causes of diverse diseases. Artin Bioscience is backed by highly respected investors and governed by a prestigious board of directors with broad industry experience. The company uses multi-modality approaches to correct intestinal dysbiosis by neutralizing the core triggers of the inflammatory process. Artin Bioscience's proprietary drug discovery platform identifies and characterizes microbial drivers of disease within precise patient subsets in certain cancers and gastrointestinal, metabolic, autoimmune, and neurodegenerative diseases. The company's world-class biobanking program collects proprietary samples and clinical data from patients and healthy controls to enable critical research into disease mechanisms and aid the development of potential treatments. | Directeur/Membre du Conseil | - | - |
Directeur Général | - | - |
Historique de carrière de Charles Joseph Magolske
Anciens postes connus de Charles Joseph Magolske
Sociétés | Poste | Début | Fin |
---|---|---|---|
TITAGARH RAIL SYSTEMS LIMITED | Directeur/Membre du Conseil | 14/02/2011 | 24/12/2012 |
Independent Dir/Board Member | 04/02/2011 | 24/12/2012 | |
FREIGHTCAR AMERICA, INC. | Corporate Officer/Principal | 15/12/2009 | 15/12/2009 |
TRINITY INDUSTRIES, INC. | Sales & Marketing | 01/01/2001 | 01/01/2002 |
OROCO RESOURCE CORP. | Corporate Officer/Principal | - | - |
AUGUSTA RESOURCE CORP. | Sales & Marketing | 16/02/2011 | - |
ARIZONA MINING INC | Corporate Officer/Principal | 21/12/2010 | - |
Formation de Charles Joseph Magolske
University of Virginia Darden School of Business | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 5 |
Canada | 4 |
Inde | 2 |
Opérationnelle
Corporate Officer/Principal | 3 |
Sales & Marketing | 2 |
Director/Board Member | 2 |
Sectorielle
Producer Manufacturing | 4 |
Non-Energy Minerals | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
TRINITY INDUSTRIES, INC. | Producer Manufacturing |
TITAGARH RAIL SYSTEMS LIMITED | Producer Manufacturing |
FREIGHTCAR AMERICA, INC. | Producer Manufacturing |
OROCO RESOURCE CORP. | Non-Energy Minerals |
Entreprise privées | 3 |
---|---|
Arizona Mining, Inc.
![]() Arizona Mining, Inc. Precious MetalsNon-Energy Minerals Arizona Mining, Inc. engaged in the exploration and development of silver, zinc and lead. The firm focuses on the Hermosa Project, which is located in Santa Cruz County, Arizona. Arizona Mining was founded on January 20, 1975 and was headquartered in Vancouver, Canada. | Non-Energy Minerals |
HudBay Arizona Corp.
![]() HudBay Arizona Corp. Other Metals/MineralsNon-Energy Minerals HudBay Arizona Corp. engaged in the exploration and development of mineral properties. The company was founded on January 14, 1937 and is headquartered in Vancouver, Canada. | Non-Energy Minerals |
Artin Bioscience, Inc.
![]() Artin Bioscience, Inc. BiotechnologyHealth Technology Artin Bioscience, Inc. is an American US-based company that is pioneering precision therapeutics to treat serious diseases triggered by intestinal inflammation. The company is creating a new class of transformative precision therapeutics that target and block the root causes of diverse diseases. Artin Bioscience is backed by highly respected investors and governed by a prestigious board of directors with broad industry experience. The company uses multi-modality approaches to correct intestinal dysbiosis by neutralizing the core triggers of the inflammatory process. Artin Bioscience's proprietary drug discovery platform identifies and characterizes microbial drivers of disease within precise patient subsets in certain cancers and gastrointestinal, metabolic, autoimmune, and neurodegenerative diseases. The company's world-class biobanking program collects proprietary samples and clinical data from patients and healthy controls to enable critical research into disease mechanisms and aid the development of potential treatments. | Health Technology |
- Bourse
- Insiders
- Charles Joseph Magolske
- Expérience